P578: GILTERITINIB FOR RELAPSED/REFRACTORY FLT3 MUTATED ACUTE MYELOID LEUKEMIA A REAL-WORLD, MULTI-CENTER, MATCHED ANALYSIS by S. Shimony, J. Canaani, E. Kugler, B. Nachmias, R. Ram, A. Frisch, C. Ganzel, V. Vainstein, Y. Moshe, S. Aumann, M. Yeshurun, Y. Ofran, P. Raanani, O. Wolach

Get full text

P562: LEMZOPARLIMAB (LEMZO) WITH VENETOCLAX (VEN) AND/OR AZACITIDINE (AZA) IN PATIENTS (PTS) WITH ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROMES (MDS): A PHASE 1B DOSE E... by J.-Z. Hou, N. G. Daver, D. A. Stevens, T. Yamauchi, Y. Moshe, C. Y. Fong, A. Marzocchetti, R. Adamec, M. Patel, S. Lambert, K. Y. Wu, C. Röllig

Get full text

P585: VENETOCLAX IN COMBINATION WITH INTENSIVE TREATMENT PROTOCOLS FOR PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA – A MULTICENTER REAL-WORLD ANALYSIS by O. Wolach, A. Frisch, L. Shargian, M. Yeshurun, A. Apel, V. Vainstein, Y. Moshe, S. Shimony, O. Amit, Y. Bar On, Y. Ofran, P. Raanani, B. Nachmias, R. Ram

Get full text

P519: TRANSFUSION INDEPENDENCE AMONG NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS RECEIVING VENETOCLAX-BASED COMBINATIONS VS OTHER THERAPIES: RESULTS FROM THE AML REAL WORLD EVI... by O. Wolach, J. S. Garcia, P. Vachhani, J. Zeidner, C. Lai, Y. Moshe, M. Xavier, S. Lee, T. Zuckerman, D. A. Pollyea, S. Abedin, E. C. Chen, S. Bathini, W. Edwards, C. N. Bui, W. W.-H. Cheng, A. Svensson, A. Guérin, J. Maitland, E. Ma, M. Montez, M. Grunspan, A. D. Goldberg

Get full text